Literature DB >> 24210227

Myosin structure, allostery, and mechano-chemistry.

Matthias Preller1, Dietmar J Manstein.   

Abstract

Aberrant actomyosin interactions contribute to a wide range of pathophysiological conditions including heart failure, neurodegenerative disorders, and tumor growth. Despite surgical, interventional, and pharmacological advances, the burden and economic impact of these diseases remains immense. The initiation and progression of these disorders is frequently found to be a direct consequence of aberrant motile activity, which makes the in-depth investigation of the molecular mechanisms underlying actomyosin-dependent motility a prerequisite for the development of innovative treatment strategies. The present review describes key structural features of the actomyosin system, the basis of chemo-mechanical and allosteric coupling in the myosin motor domain, and molecular engineering and small molecule-based approaches to alter myosin function.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24210227     DOI: 10.1016/j.str.2013.09.015

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  29 in total

1.  Phenamacril is a reversible and noncompetitive inhibitor of Fusarium class I myosin.

Authors:  Rasmus D Wollenberg; Manuel H Taft; Sven Giese; Claudia Thiel; Zoltán Balázs; Henriette Giese; Dietmar J Manstein; Teis E Sondergaard
Journal:  J Biol Chem       Date:  2018-11-30       Impact factor: 5.157

2.  Converter domain mutations in myosin alter structural kinetics and motor function.

Authors:  Laura K Gunther; John A Rohde; Wanjian Tang; Shane D Walton; William C Unrath; Darshan V Trivedi; Joseph M Muretta; David D Thomas; Christopher M Yengo
Journal:  J Biol Chem       Date:  2018-12-05       Impact factor: 5.157

3.  FRET and optical trapping reveal mechanisms of actin activation of the power stroke and phosphate release in myosin V.

Authors:  Laura K Gunther; John A Rohde; Wanjian Tang; Joseph A Cirilo; Christopher P Marang; Brent D Scott; David D Thomas; Edward P Debold; Christopher M Yengo
Journal:  J Biol Chem       Date:  2020-12-18       Impact factor: 5.157

4.  Molecular mechanisms underlying deoxy-ADP.Pi activation of pre-powerstroke myosin.

Authors:  Sarah G Nowakowski; Michael Regnier; Valerie Daggett
Journal:  Protein Sci       Date:  2017-03-21       Impact factor: 6.725

5.  FRET and optical trapping reveal mechanisms of actin-activation of the power stroke and phosphate-release in myosin V.

Authors:  Laura K Gunther; John A Rohde; Wanjian Tang; Joseph A Cirilo; Christopher P Marang; Brent D Scott; David D Thomas; Edward P Debold; Christopher M Yengo
Journal:  J Biol Chem       Date:  2020-10-14       Impact factor: 5.157

Review 6.  Update on Myosin Motors: Molecular Mechanisms and Physiological Functions.

Authors:  Jennifer M Ryan; Andreas Nebenführ
Journal:  Plant Physiol       Date:  2017-11-21       Impact factor: 8.340

7.  High-resolution helix orientation in actin-bound myosin determined with a bifunctional spin label.

Authors:  Benjamin P Binder; Sinziana Cornea; Andrew R Thompson; Rebecca J Moen; David D Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-08       Impact factor: 11.205

8.  Plasma skeletal muscle myosin phenotypes identified by immunoblotting are associated with pulmonary embolism occurrence in young adults.

Authors:  Taichi K Deguchi; Hiroshi Deguchi; Zihan Guo; Darlene J Elias; John H Griffin
Journal:  Thromb Res       Date:  2020-02-27       Impact factor: 3.944

9.  N-terminal splicing extensions of the human MYO1C gene fine-tune the kinetics of the three full-length myosin IC isoforms.

Authors:  Lilach Zattelman; Ronit Regev; Marko Ušaj; Patrick Y A Reinke; Sven Giese; Abraham O Samson; Manuel H Taft; Dietmar J Manstein; Arnon Henn
Journal:  J Biol Chem       Date:  2017-09-11       Impact factor: 5.157

10.  Prothrombotic skeletal muscle myosin directly enhances prothrombin activation by binding factors Xa and Va.

Authors:  Hiroshi Deguchi; Ranjeet K Sinha; Patrizia Marchese; Zaverio M Ruggeri; Jevgenia Zilberman-Rudenko; Owen J T McCarty; Mitchell J Cohen; John H Griffin
Journal:  Blood       Date:  2016-07-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.